Advanced post-neoadjuvant treatment of early triple negative breast cancer (TNBC) with autologous cell immunotherapy

Code:

J3-60066

Range:

01. January 2025 - 31. December 2027

Range:

0,25 FTE

Leader:

Matjaž Jeras

Field:

3.04 Medical Sciences/Oncology

Research Organisation:

https://cris.cobiss.net/ecris/si/en/project/22708

Researchers:

https://cris.cobiss.net/ecris/si/en/project/22708

Content:

https://cris.cobiss.net/ecris/si/en/project/22708

Phases:

https://cris.cobiss.net/ecris/si/en/project/22708

Bibliographical references, arising directly from the implementation of the project:

https://cris.cobiss.net/ecris/si/en/project/22708

Financed by:

Research projects (co)funded by the Slovenian Research Agency.